Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
Aurobindo Pharma Dividend Announcement
• Aurobindo Pharma announced a semi annually dividend of ₹1.50 per ordinary share which will be made payable on . Ex dividend date: 2024-02-20
• Aurobindo Pharma annual dividend for 2024 was ₹1.50
• Aurobindo Pharma annual dividend for 2023 was ₹6.00
• Aurobindo Pharma's trailing twelve-month (TTM) dividend yield is 0.36%
• Aurobindo Pharma's dividend growth over the last five years (2018-2023) was 21.67% year
• Aurobindo Pharma's dividend growth over the last ten years (2013-2023) was 8.11% year
Aurobindo Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-02-20 | ₹1.50 | semi annually | |
2023-11-20 | ₹3.00 | semi annually | 2023-12-04 |
2023-02-17 | ₹3.00 | semi annually | 2023-03-03 |
2022-06-06 | ₹4.50 | semi annually | 2022-06-15 |
2022-02-18 | ₹1.50 | semi annually | 2022-03-04 |
2021-11-17 | ₹1.50 | semi annually | 2021-11-30 |
2021-08-27 | ₹1.50 | semi annually | 2021-09-07 |
2021-02-22 | ₹1.50 | semi annually | 2021-03-04 |
2020-11-23 | ₹1.25 | semi annually | 2020-12-04 |
2020-08-21 | ₹1.25 | semi annually | 2020-09-04 |
2020-02-17 | ₹1.75 | semi annually | 2020-03-02 |
2019-11-21 | ₹1.25 | semi annually | 2019-12-04 |
2019-02-15 | ₹1.25 | semi annually | 2019-02-28 |
2018-11-20 | ₹1.25 | semi annually | 2018-11-30 |
2018-02-20 | ₹1.00 | semi annually | 2018-02-28 |
2017-11-21 | ₹1.50 | semi annually | 2017-11-30 |
2017-06-08 | ₹1.25 | semi annually | 2017-06-21 |
2016-11-24 | ₹1.25 | semi annually | 2016-12-09 |
2016-06-09 | ₹0.70 | semi annually | 2016-06-22 |
2016-02-18 | ₹0.70 | semi annually | 2016-03-01 |
2015-11-19 | ₹0.60 | semi annually | 2015-11-27 |
2015-08-21 | ₹0.50 | semi annually | 2015-09-04 |
2015-06-08 | ₹1.00 | semi annually | 2015-06-23 |
2015-02-16 | ₹2.00 | semi annually | 2015-02-25 |
2014-08-13 | ₹1.50 | semi annually | 2014-09-05 |
2014-06-11 | ₹1.75 | semi annually | 2014-06-25 |
2013-11-19 | ₹1.25 | semi annually | 2013-12-07 |
2013-07-30 | ₹0.50 | semi annually | 2013-09-06 |
2013-02-18 | ₹1.00 | semi annually | 2013-03-09 |
Aurobindo Pharma Dividend per year
Aurobindo Pharma Dividend growth
Aurobindo Pharma Dividend Yield
Aurobindo Pharma current trailing twelve-month (TTM) dividend yield is 0.36%. Interested in purchasing Aurobindo Pharma stock? Use our calculator to estimate your expected dividend yield:
Aurobindo Pharma Financial Ratios
Aurobindo Pharma Dividend FAQ
Other factors to consider when evaluating Aurobindo Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Aurobindo Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Aurobindo Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Aurobindo Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Aurobindo Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Aurobindo Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Aurobindo Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Aurobindo Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Aurobindo Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Aurobindo Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Aurobindo Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.